Company / Capital Expenditures
Nuo Therapeutics, Inc. Capital Expenditures History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$698.2K
FY2015
5-year range
$483.0K / $750.7K
FY2011-FY2015
Trend
+44.6%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $750,697 to $698,172 over the past 2 years.
Based on SEC 10-K filings.
$698,172 in FY2015.
Declined from $750,697 to $698,172 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, capital expenditures increased 44.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | $698.2K | +44.6% |
| FY2014 | $483.0K | -35.7% |
| FY2013 | $750.7K | - |
| FY2012 | - | - |
| FY2011 | $66.4K | - |
As of FY2015 · SEC 10-K · Updated Jun 29, 2026